peroxynitrous acid has been researched along with Hypertrophy, Right Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, R; Li, J; Pei, JM; Wang, HY; Wang, QL; Wang, YM; Wu, Q; Xu, XZ; Yi, DH; Yu, SQ; Zhao, L; Zhou, P | 1 |
| Ivanovska, J; Jankov, RP; Kantores, C; Lee, AH; Lewis, P; McNamara, PJ; Tanswell, AK; Van Vliet, T; Xu, EZ | 1 |
2 other study(ies) available for peroxynitrous acid and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Acetylcholine; Animals; Blood Pressure; Endothelium, Vascular; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Phosphorylation; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Superoxides; Vasodilation; Ventricular Pressure | 2013 |
Peroxynitrite mediates right-ventricular dysfunction in nitric oxide-exposed juvenile rats.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Apoptosis; Disease Models, Animal; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Metalloporphyrins; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Rats; Tyrosine; Vascular Resistance; Ventricular Dysfunction, Right | 2010 |